Phase 3 Study of KP-100LI in Subjects With Vocal Fold Scar

Clinical trial NCT05627648 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05627648
Sponsor: Kringle Pharma, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Vocal Fold Scar

Start date: 2022-12-01
Primary completion: 2026-07-31
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.